Table 1 Characteristics of the patients
Category | Study group | Control group | P-value |
|---|---|---|---|
No. of hips | 42 | 42 | Â |
Age, yr | 39.1 ± 9.8 | 39.4 ± 8.9 | 0.617 |
BMI, kg/m2 | 24.1 ± 3.0 | 23.5 ± 3.0 | 0.356 |
Sex, n (%) | Â | Â | 0.827 |
 Female | 20 (47.6) | 19 (45.2) |  |
 Male | 22 (52.4) | 23 (54.8) |  |
Follow-up time, m | 36.1 ± 3.2 | 35.3 ± 3.6 | 0.714 |
Cholesterol | 5.2 ± 0.71 | 4.2 ± 0.53 | < 0.001 |
Triglyceride | 1.9 ± 0.98 | 1.1 ± 0.4 | < 0.001 |
LCEA preoperative | 35.5 ± 5.5 | 35.4 ± 5.6 | 0.934 |
LCEA postoperative | 29.2 ± 4.5 | 29.6 ± 5.1 | 0.728 |
Alpha preoperative | 63.8 ± 9.2 | 63.7 ± 8.1 | 0.945 |
Alpha postoperative | 42.5 ± 5.0 | 41.4 ± 4.2 | 0.273 |